Grape seed proanthocyanidins correct dyslipidemia associated with a high-fat diet in rats and repress genes controlling lipogenesis and VLDL assembling in liver

International Journal of Obesity

Volumn 33, Issue 9, 2009, Pages 1007-1012

  Quesada, H ^a   Del Bas, J M ^a   Pajuelo, D ^a   Diaz S ^a   Fernandez Larrea, J ^a   Pinent, M ^a   Arola, L ^a   Salvado M J ^a   Blade C ^a  

^a UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

High fat diet; Liver; MTP; Proanthocyanidins; SREBP1; Triglycerides

Indexed keywords

CARRIER PROTEIN; CHOLESTEROL; DIACYLGLYCEROL ACYLTRANSFERASE; FATTY ACID; GRAPE SEED EXTRACT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROANTHOCYANIDIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; DGAT2 PROTEIN, HUMAN; FAT INTAKE; GRAPE SEED PROANTHOCYANIDINS;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; COLORIMETRY; CONTROLLED STUDY; DRUG MECHANISM; DYSLIPIDEMIA; FATTY LIVER; FEMALE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE REPRESSION; GRAPE; GRAVIMETRY; HOMEOSTASIS; HYPERCHOLESTEROLEMIA; LIPID DIET; LIPID LIVER LEVEL; LIPID PEROXIDATION; LIPOGENESIS; LIVER; MUSCLE TISSUE; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; ADMINISTRATION AND DOSAGE; ANIMAL; BLOOD; DRUG EFFECTS; DYSLIPIDEMIAS; FAT INTAKE; METABOLISM; WISTAR RAT;

ANIMALS; CHOLESTEROL, LDL; DIACYLGLYCEROL O-ACYLTRANSFERASE; DIETARY FATS; DYSLIPIDEMIAS; FEMALE; GRAPE SEED EXTRACT; LIPOGENESIS; LIPOPROTEINS, VLDL; LIVER; PROANTHOCYANIDINS; RATS; RATS, WISTAR; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIGLYCERIDES;

RATTUS; RATTUS NORVEGICUS; VITACEAE;

EID: 70349119490     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2009.136     Document Type: Article

References (26)

1. Hokanson JE. Hypertriglyceridemia and risk of coronary heart disease. Curr Cardiol Rep 2002; 4: 488-493.
2. Yuan G, Al-Shali KZ, Hegele RA. Hypertriglyceridemia: its etiology, effects and treatment. CMAJ 2007; 176: 1113-1120.
3. Riches FM, Watts GF, Naoumova RP, Kelly JM, Croft KD, Thompson GR. Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity. Int J Obes Relat Metab Disord 1998; 22: 414-423.
4. Ginsberg HN, Zhang YL, Hernandez-Ono A. Regulation of plasma triglycerides in insulin resistance and diabetes. Arch Med Res 2005; 36 : 232-240.
5. Nesto RW. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome. Am J Cardiovasc Drugs 2005; 5: 379-387.
6. Watts GF, Herrmann S, Riches FM. Effects of diet and serotonergic agonist on hepatic apolipoprotein B-100 secretion and endo-thelial function in obese men. QJM 2000; 93: 153-161.
7. Prior RL, Gu L. Occurrence and biological significance of proanthocyanidins in the American diet. Phytochemistry 2005; 66 : 2264-2280.
8. Aron P, Kennedy J. Flavan-3-ols: nature, occurrence and biological activity. Mol Nutr Food Res 2008; 52: 79-104.
9. Bagchi D, Sen CK, Ray SD, Das DK, Bagchi M, Preuss HG et al. Molecular mechanisms of cardioprotection by a novel grape seed proanthocyanidin extract. Mutat Res 2003; 523-524: 87-97.
10. Auger C, Gerain P, Laurent-Bichon F, Portet K, Bornet A, Caporiccio B et al. Phenolics from commercialized grape extracts prevent early atherosclerotic lesions in hamsters by mechanisms other than antioxidant effect. J Agric Food Chem 2004; 52: 5297-5302.
11. Kar P, Laight D, Shaw KM, Cummings MH. Flavonoid-rich grapeseed extracts: a new approach in high cardiovascular risk patients? Int J Clin Pract 2006; 60: 1484-1492.
12. Del Bas JM, Fernández-Larrea J, Blay M, Ardévol A, Salvadó MJ, Arola L et al. Grape seed procyanidins improve atherosclerotic risk index and induce liver CYP7A1 and SHP expression in healthy rats. FASEB J 2005; 19: 479-481.
13. Zern TL, Wood RJ, Greene C, West KL, Liu Y, Aggarwal D et al. Grape polyphenols exert a cardioprotective effect in pre- and postmenopausal women by lowering plasma lipids and reducing oxidative stress. J Nutr 2005; 135: 1911-1917.
14. Castilla P, Echarri R, Davalos A, Cerrato F, Ortega H, Teruel JL et al. Concentrated red grape juice exerts antioxidant, hypolipidemic, and antiinflammatory effects in both hemodialysis patients and healthy subjects. Am J Clin Nutr 2006; 84: 252-262.
15. Del Bas JM, Ricketts M, Baiges I, Quesada H, Ardévol A, Salvadó MJ et al. Dietary procyanidins lower triglyceride levels signaling through the nuclear receptor small heterodimer partner. Mol Nutr Food Res 2008; 52: 1172-1181.
16. Puigserver P, Llado I, Palou A, Gianotti M. Evidence for masking of brown adipose tissue mitochondrial GDP-binding sites in response to fasting in rats made obese by dietary manipulation. Effects of reversion to standard diet. Biochem J 1991; 279: 575-579.
17. Draeger B, Wahlefeld AW, Ziegenhornvol J. HDL-cholesterol. In: Bergmeyer, H.U., (ed) Methods of Enzymatic Analysis. Academic Press: New York, 1985, pp 148-154.
18. Kerscher L, Draeger B, Maier J, Ziegenhorn J. LDL-cholesterol. In: Bergmeyer, H.U., (ed) Methods of Enzymatic Analysis. Academic Press: New York, 1985, pp 154-160.
19. Folch J, Lees M, Stanley G. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957; 226: 497-509.
20. Bamba V, Rader DJ. Obesity and atherogenic dyslipidemia. Gastroenterology 2007; 132: 2181-2190.
21. Rothwell NJ, Stock MJ. The cafeteria diet as a tool for studies of thermogenesis. J Nutr 1988; 118: 925-928.
22. Ferre P, Foufelle F. SREBP-1c transcription factor and lipid homeostasis: clinical perspective. Horm Res 2007; 68: 72-82.
23. Gibbons GF, Wiggins D, Brown AM, Hebbachi AM. Synthesis and function of hepatic very-low-density lipoprotein. Biochem Soc Trans 2004; 32: 59-64.
24. Ramsay RR, Gandour RD, van der Leij FR. Molecular enzymology of carnitine transfer and transport. Biochim Biophys Acta 2001; 1546: 21-43.
25. Watanabe M, Houten SM, Wang L, Moschetta A, Mangelsdorf DJ, Heyman RA et al. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J Clin Invest 2004; 113: 1408-1418.
26. Bavner A, Sanyal S, Gustafsson JA, Treuter E. Transcriptional corepression by SHP: molecular mechanisms and physiological consequences. Trends Endocrinol Metab 2005; 16: 478-488.